Stratipath pricing

No pricing is published. Stratipath Breast is sold as a software as a service subscription, through the company's portal or partner platforms, and the company positions it as a faster and cheaper alternative to gene expression tests, with results within one hour. No subscription fee, per case rate or tier is stated.

Stratipath full profile Stratipath alternatives

Pricing terms

How Stratipath pricing works

Pricing model: Undisclosed. Single product prognostic analysis on routine H and E slides, sold directly and through a partner platform.
Implementation: Not disclosed. Available through PathAI's AISight platform since 2025, so laboratories already on that platform face algorithm enablement rather than integration.
Business associate agreement: Not disclosed. CE-IVD marked for European clinical use rather than FDA cleared, so a US engagement would require terms established directly or via a host platform.

Compared on price

Stratipath pricing against its alternatives

Published prices for Stratipath and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.

All Stratipath alternatives →

S
StratipathNo published price
W
WaivNo published price
P
PreciseDxNo published price
A
AiforiaNo published price
D
DoMore DiagnosticsNo published price
P
PrimaaNo published price
M
MindpeakNo published price
A
ArteraAINo list price published; patient cost $0 to $285 under the financial assistance program, and none for covered Medicare patients
P
PathAINo published price

Questions

Stratipath pricing, answered

How much does Stratipath cost?

Stratipath does not publish a price. Stratipath Breast is sold as a software as a service subscription, through the company's portal or partner platforms, and the company positions it as a faster and cheaper alternative to gene expression tests, with results within one hour. No subscription fee, per case rate or tier is stated.

Does Stratipath charge an implementation fee?

Not disclosed. Available through PathAI's AISight platform since 2025, so laboratories already on that platform face algorithm enablement rather than integration.

Does Stratipath offer a business associate agreement?

Not disclosed. CE-IVD marked for European clinical use rather than FDA cleared, so a US engagement would require terms established directly or via a host platform.